Navigation Links
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Date:3/7/2008

LAUSANNE, Switzerland, March 7 /PRNewswire/ -- Galderma Pharma, S.A. announces an agreement with ZARS Pharma, Inc. giving Galderma exclusive rights for all markets outside the USA and Canada for promotion and distribution of a novel topical anesthetic cream. This partnership follows an agreement signed last year between Galderma and ZARS Pharma for the promotion and distribution of Pliaglis(TM) in the USA and Canada.

"This agreement gives us a new opportunity to contribute to progress in patient care worldwide," said Humberto C. Antunes, CEO of Galderma. "As the market for corrective and aesthetic procedures continues to grow, Pliaglis(TM), with its unique vehicle and comfort of use for both patient and doctor is poised to fill an important unmet need. This agreement is part of our strategy to offer a comprehensive range of products that improve corrective and aesthetic procedural outcomes and complement our current family of therapeutic Rx and OTC products throughout the world."

Pliaglis(TM) (lidocaine and tetracaine) Cream 7%/7% is the first FDA-approved prescription-strength lidocaine and tetracaine combination topical anesthetic cream indicated to provide topical local analgesia for superficial dermatological procedures such as, among others, dermal filler injections, facial laser resurfacing and laser-assisted tattoo removal.

Formulated in a unique cream vehicle, Pliaglis(TM) is easily applied to the skin and forms a pliable self-occlusive mask which is easily peeled off the skin prior to a procedure. Pliaglis(TM) is a versatile new tool for use in many of the most common corrective and aesthetic procedures. With proven clinical efficacy, a unique phase-changing vehicle and an onset of action between 20-30 minutes, Pliaglis(TM) represents a technological innovation in patient's comfort.

"We are convinced that Pliaglis(TM) will be very well received by dermatologists and other physicians in Europe and Asia," said Francois Fourn
'/>"/>

SOURCE Galderma Pharma, S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
2. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
3. Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players
4. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
5. GeoPharma, Inc. to Present at the EdgeWater Research Investor Conference
6. FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM)
7. Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
8. Conseco Files to Formally Extend Due Date for Annual Report on Form 10-K to March 17 and Reschedules Earnings Release and Investor Call
9. FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
10. Actavis Extends Portfolio With Four New Products in the U.S.
11. CDC Panel Urges Extending Flu Vaccine Coverage for Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Dynamic health trends, changing ... in the Bread Production industry over the past ... moderate their consumption of a variety of industry ... shrunk the market for white loaf bread and ... by introducing more nutritious products to attract health-conscious ...
(Date:9/30/2014)... September 30, 2014(BRONX, NY)Medications are the leading cause of ... analysis of death certificates from 1999 to 2010, conducted ... and Albert Einstein College of Medicine of Yeshiva ... Journal of Allergy and Clinical Immunology , also ... was particularly high among older people and African-Americans and ...
(Date:9/30/2014)... NV (PRWEB) September 30, 2014 Fat ... nutrition specialist and best-selling author Mike Geary that is helping ... transform their body into a fat-burning machine in less than ... an investigative review. , “In our culture that is ... be hard to decipher what is really fact and fiction ...
(Date:9/30/2014)... Eagan, Minn. (PRWEB) September 30, 2014 ... trips to the apple orchard, pumpkin patch or annual ... season for fast-spreading viruses – like the respiratory infection ... cold in most children, a small percentage – especially ... severe symptoms. Increased concern about the Enterovirus is prompting ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 A group of ... to combat an epidemic that, left unchecked, could create a ... are not headed to Africa. John Rogers, the Executive Director ... North Korea to fight a disease most think mankind conquered ... some 80 years ago is on the comeback in several ...
Breaking Medicine News(10 mins):Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:As Hospitals Combat Enterovirus Outbreaks, Patients and Families Turn to “Virtual Visits” with CaringBridge 2Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2
... Assembly elected new officers and members of its national board of ... Conference in Washington, D.C.New officers include:, , ... Director of YWCA York, Pennsylvania , ... Chicago, Illinois , Secretary: ...
... is standing up against insurance companies and big business , ... New ... lawyers can have a tough time against large pocketed companies such ... these monsters want the public to believe it is they who are ...
... and experts will gather in New Orleans on June ... health and property damage controversy involving building materials: ... for two teleconferences dealing with the insurance implications on ... According to the Consumer Product Safety Commission, at least ...
... For 7-year-old Alexander, it,s meant orthotics and physical therapy ... 7-year-old Rebecca, it,s an insulin pump for her Type ... cerebral palsy, it,s a wheelchair.All these children and more ... the UnitedHealthcare Children,s Foundation (UHCCF) in recent years to ...
... CME LL C ... Initiatives. In her new role, DeMatteo will guide the ... through activities founded on proven learning adult principles, delivered ... CME LLC more ...
... Pa., May 12 The Pennsylvania Department of Aging and ... a 15-member Quality Council that will advise on new policies ... services. "Many older citizens and those with disabilities prefer to ... nursing facility -- so we want to make sure that ...
Cached Medicine News:Health News:YWCA USA Elects New National Leadership Team 2Health News:Manhattan Personal Injury Attorney Blames Insurance Industry For Negative Perception Of Civil Justice System 2Health News:Chinese Drywall Litigation Subject of Conference and Two Teleconferences 2Health News:UnitedHealthcare Children's Foundation To Award More Medical Grants for Child Health Care Needs in Connecticut 2Health News:Ann Marie DeMatteo Joins CME LLC as Vice President of Educational Initiatives, Drives Innovative Programming Approaches 2Health News:Pennsylvania Council Formed to Advise on Improving Services to Older Adults, People with Disabilities 2
(Date:9/30/2014)... 2014   Acutus Medical, Inc. (ACM), ... 3D Cardiac Chamber Imaging and Dipole Density Mapping system ... sustain complex cardiac arrhythmias, including atrial fibrillation, announced it ... its imaging/mapping system as well as bring to market ... Medical to complete work on the AcQMap TM ...
(Date:9/30/2014)... In 2011, approximately 5.1 million people in ... pain relievers (e.g. opioids). 1 Clinical treatments for ... the use of buprenorphine, buprenorphine/naloxone, naltrexone or methadone. The ... developing and improving care management programs, according to ... Therapeutics LLC (Prime). Cost trends ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014  Life ... group focused on supporting promising emerging biotech, medical ... been named the Top Angel Investment Group in ... as the best performer out of 370 angel ... historical performance, network strength (connections), selection aptitude and ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3
... Top Line Data Is Expected to Be Presented in ... VIA Pharmaceuticals,(Nasdaq: VIAP ), a biotechnology company focused ... disease, announced today that,it has completed patient enrollment in ... 2 trials investigating VIA-2291, the,company,s lead product candidate., ...
... Effects are not the Only Way We Suffer - ... Allergies Impact Mood and Self-Perception, KENILWORTH, ... allergies affect about 50,million people in the United States.(1)(2) Yet, ... often,disregarded as a nuisance: in today,s society allergies get little ...
Cached Medicine Technology:VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 2VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 3VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 4VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 2New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 3New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 6New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: